ZYME - Billionaires Are Gobbling Up These 3 Healthcare Stocks
Keeping tabs on the quarterly activity of billionaire superinvestors can be a great way to unearth hidden gems, or perhaps avoid potential potholes. Billionaires, after all, are rich for a reason. When it comes to the complex but rewarding area of healthcare, Baker Brothers Advisors, a hedge fund run by billionaire brothers Felix and Julian Baker, is without question the best in the game at picking big winners in this volatile sector.
While Felix and Julian Baker haven't always been spot on with their healthcare stock picks, they have hit the jackpot numerous times over the years. Some of their best picks to date include top growth stocks like Axsome Therapeutics, Exact Sciences, and GW Pharmaceuticals plc. So when the Baker Brothers start to pour money into a little known healthcare company, it's probably a good idea to take note.
Which relatively unknown stocks have the Baker Brothers been quietly gobbling up in 2020? The fund recently disclosed massive buys in Aurinia Pharmaceuticals (NASDAQ: AUPH), Kodiak Sciences (NASDAQ: KOD), and Zymeworks (NYSE: ZYME). Are these biotech growth stocks suitable for everyday investors? Let's dig deeper to find out.